Aug 192004
 

I am exceptionally displeased with Biogen’s decision to withhold the 1yr. phase III results on Antegren until it is approved by the FDA. I am not at all buying there excuse that the expected 6 weeks until it has FDA approval would at all impact their 2yr. phase III trial. What it does is withhold information that I and my doctor need to make an informed decision as how to proceed with Antegren. This will only serve to delay any move I make and seems to indicate that they are less then loyal to the Multiple Sclerosis community. I have sent an e-mail to Biogen at public.affairs@biogenidec.com and I urge everyone else to send one too urging them to reconsider their delay in disclosing the study information. I think I may have to agree with this article’s comment: “Call me a glass-half-empty guy (it won’t be the first time), but this latest development has me wondering whether there’s something amiss with Antegren.”

 Posted by at 7:36 pm

  One Response to “Biogen Ticking Me Off on Antegren Study Results”

  1. Ah the joys and evils of the return-receipt in e-mail. I’m a little surprised that they have their e-mail set to accept RR requests to what is probably a group e-mail account. Well Lauren DiCola (Lauren.DiCola@biogenidec.com) read my message at 8:47 this morning at what appears to be their Cambridge office. The big question is will I get a response?!?!

 Leave a Reply

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

(required)

(required)

*